'Not Diuresing' After Three Days of IV Furosemide
Mrs. K is 78 and was admitted three days ago with decompensated heart failure; ejection fraction is 25%. She has received furosemide 80 mg IV twice daily and has lost only 0.8 kg. Overnight her blood pressure fell from a baseline of 122/74 to 86/58, heart rate 104, respirations 26, SpO2 92% on 2 L. Her hands and knees are cool and mottled, urine output is 20 mL/hour, and she remains orthopneic with crackles to mid-lung and jugular venous pressure of 12 cm. Lactate is 3.1 mmol/L and creatinine has risen from 1.3 to 1.9 mg/dL. Medications: carvedilol 12.5 mg twice daily, sacubitril/valsartan 97/103 mg twice daily, spironolactone 25 mg daily, empagliflozin 10 mg daily. The night nurse documents 'not diuresing, needs a bigger dose.'
1. Interpret this picture. Is the problem inadequate diuresis, or low cardiac output, and what findings support each? What is the immediate clinical priority?
Read the worked answer
This is a 'cold and wet' profile - low cardiac output with persistent congestion - not simple under-diuresis.
Evidence of low output: cool, mottled hands and knees; MAP of 67 on a narrowed pulse pressure (86/58); urine output 20 mL/hour; rising lactate (3.1); and a creatinine climbing from 1.3 to 1.9.
Evidence of ongoing congestion: orthopnea, crackles to mid-lung, JVP 12 cm - not euvolemic.
The trap in the nurse's note is assuming the rising creatinine means over-diuresis. In a low-output state, renal perfusion falls, diuretics are delivered poorly to the tubular lumen, and creatinine rises because the heart is failing, not because the patient is dry. Giving 160 mg IV would be treating the laboratory number and worsening the physiology: more renin-angiotensin activation, less renal perfusion, more hypotension.
Priority: restore forward flow while continuing controlled decongestion in a monitored setting. This patient needs provider notification, telemetry or intensive care, and consideration of an inotrope - not a dose increase.
2. Which of her cardiac medications should be held or changed in the next few hours, and why? Distinguish holding from discontinuing.
Read the worked answer
Hold now (not discontinue - reassess as perfusion improves):
- Carvedilol - a negative inotrope and chronotrope in a patient with cool extremities, hypotension, and rising lactate. Continuing it worsens low output.
- Sacubitril/valsartan - potent afterload reduction at 86/58, plus further renal risk in a rising creatinine. Angiotensin blockade plus hypotension is a worsening-renal-function combination.
- Spironolactone - hold while creatinine is rising and potassium is unknown; hyperkalemia risk is highest exactly at this moment.
- Empagliflozin - generally beneficial in heart failure, but with hypotension, hypoperfusion, and poor intake, the risk of volume depletion and euglycemic ketosis rises; hold until perfusion is restored.
Do not give additional bolus furosemide or any vasodilator such as IV nitroglycerin - her blood pressure cannot tolerate afterload reduction, and vasodilation in a low-output state precipitates collapse.
Continue: oxygen and monitoring; strict intake and output (a urinary catheter is justified here for accurate measurement); daily weights.
Document clearly that these agents are held with a restart plan so they are not silently dropped from the discharge list.
3. What should you recommend for escalation, and when would you move from diuretic therapy to inotrope support? What monitoring matters most?
Read the worked answer
Escalation: notify the provider or rapid response immediately; move to a telemetry or cardiac intensive care bed. Lactate 3.1 with mottling and oliguria is organ hypoperfusion, not a routine floor situation.
Diuretic to inotrope: when congestion persists and perfusion is inadequate - exactly this scenario - add an inotrope rather than escalating the loop diuretic alone. Dobutamine is a reasonable first choice; milrinone is often preferred with elevated pulmonary pressures or concurrent beta-blockade, but it is renally cleared and longer-acting, so hypotension risk is higher. Once forward flow improves, the same or lower diuretic dose will often produce a better response. If she remains hypotensive despite inotrope and volume status is unclear, bedside echocardiography guides the decision.
Monitoring priorities:
- Continuous blood pressure and rhythm; hourly urine output.
- Serum potassium and magnesium (renal failure plus spironolactone plus an ARNI).
- Renal function 12–24 hours after any change.
- Lactate trend and mentation - the earliest signs that perfusion is or is not being restored.
- Daily weight at the same time on the same scale.
A rising creatinine with improving lactate, warm extremities, and better urine output is acceptable; a rising creatinine with persistent mottling is failure of the plan.